Curis Inc.

8.00-0.4000-4.76%Vol 877.41K1Y Perf 675.48%
Sep 24th, 2021 16:00 DELAYED
BID8.01 ASK8.02
Open8.30 Previous Close8.40
Pre-Market- After-Market8.03
 - -  0.03 0.37%
Target Price
22.00 
Analyst Rating
— 0.00
Potential %
175.00 
Finscreener Ranking
★★★★★     59.13
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★★     55.82
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★+     57.30
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
42.61 
Earnings Rating
Strong Sell
Market Cap732.77M 
Earnings Date
9th Nov 2021
Alpha0.04 Standard Deviation0.65
Beta2.93 

Today's Price Range

8.008.31

52W Range

1.0217.40

5 Year PE Ratio Range

-2.50-2.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-5.66%
1 Month
-0.50%
3 Months
3.90%
6 Months
-32.32%
1 Year
675.48%
3 Years
403.14%
5 Years
-35.48%
10 Years
-48.05%

TickerPriceChg.Chg.%
CRIS8.00-0.4000-4.76
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Financial StrengthValueIndustryS&P 500US Markets
19.70
19.90
0.04
0.05
-6.10
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
95.00
-287.40
-285.80
-450.20
-
RevenueValueIndustryS&P 500US Markets
10.24M
0.11
0.17
6.51
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.11-0.12-9.09
Q01 2021-0.09-0.11-22.22
Q04 2020-0.07-0.11-57.14
Q03 2020--0.11-
Q02 2020--0.17-
Q01 2020--0.28-
Q04 2019--0.26-
Q03 2019--0.19-
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.13-18.18Negative
12/2021 QR-0.14-16.67Negative
12/2021 FY-0.49-11.36Negative
12/2022 FY-0.53-32.50Negative
Next Report Date9th Nov 2021
Estimated EPS Next Report-0.13
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume877.41K
Shares Outstanding91.60M
Shares Float91.36M
Trades Count6.22K
Dollar Volume11.27M
Avg. Volume2.46M
Avg. Weekly Volume866.23K
Avg. Monthly Volume1.08M
Avg. Quarterly Volume1.77M

Curis Inc. (NASDAQ: CRIS) stock closed at 8 per share at the end of the most recent trading day (a -4.76% change compared to the prior day closing price) with a volume of 883.77K shares and market capitalization of 732.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 28 people. Curis Inc. CEO is James E. Dentzer.

The one-year performance of Curis Inc. stock is 675.48%, while year-to-date (YTD) performance is -2.32%. CRIS stock has a five-year performance of -35.48%. Its 52-week range is between 1.02 and 17.4, which gives CRIS stock a 52-week price range ratio of 42.61%

Curis Inc. currently has a PE ratio of -19.70, a price-to-book (PB) ratio of 6.91, a price-to-sale (PS) ratio of 71.28, a price to cashflow ratio of 36.40, a PEG ratio of 2.32, a ROA of -29.97%, a ROC of -61.86% and a ROE of -85.20%. The company’s profit margin is -%, its EBITDA margin is -285.80%, and its revenue ttm is $10.24 Million , which makes it $0.11 revenue per share.

Of the last four earnings reports from Curis Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Curis Inc.’s next earnings report date is 09th Nov 2021.

The consensus rating of Wall Street analysts for Curis Inc. is (0), with a target price of $22, which is +175.00% compared to the current price. The earnings rating for Curis Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Curis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Curis Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.96, ATR14 : 0.39, CCI20 : -116.67, Chaikin Money Flow : 0.25, MACD : 0.06, Money Flow Index : 50.51, ROC : -3.03, RSI : 46.67, STOCH (14,3) : 18.89, STOCH RSI : 0.05, UO : 54.96, Williams %R : -81.11), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Curis Inc. in the last 12-months were: James E. Dentzer (Sold 5 377 shares of value $57 780 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

CEO: James E. Dentzer

Telephone: +1 617 503-6500

Address: 4 Maguire Road, Lexington 02421, MA, US

Number of employees: 28

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

80%20%

Bearish Bullish

55%45%

Bearish Bullish

65%35%

News

Stocktwits